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http://dx.doi.org/10.1016/j.bpj.2014.11.1852Myosin binding protein-C (MyBP-C) is a regulatory protein
in striated muscle (1). Its function is not well understood,
but in cardiac muscle it modulates contraction and relaxa-
tion rates and contributes to contractile reserve in response
to inotropic stimuli (2). Mutations inMYBPC3, the gene en-
coding the cardiac isoform, cMyBP-C, cause cardiomyopa-
thies; altered function of cMyBP-C due to posttranslational
modification is prevalent in heart failure (3). Understanding
cMyBP-C’s role in muscle contraction is therefore impor-
tant in both health and disease. Here, by developing a math-
ematical model and fitting published in vitro measurements
that serve as a simplified model of the more complex in vivo
system, we provide evidence cMyBP-C acts via a drag-
activation-competition mechanism.
cMyBP-C interacts with proteins that generate (4,5) and
regulate (6,7) muscle force. Muscle contraction is powered
by cyclic interactions of myosin with actin, proteins that
occur, respectively, in thick and thin filaments. Myosin
motors turn chemical energy in ATP into mechanical work
by binding to actin and sliding the thin filament relative
to the thick filament. In vertebrate striated muscle, this
process is regulated by thin-filament associated proteins,
troponin and tropomyosin. Tropomyosin filaments wrap
around actin, sterically blocking myosin from binding to
actin. The block is partly removed when calcium binds to
troponin, which changes conformation and moves tropomy-
osin from the blocked toward the open position (Fig. 1 A).
Parts of cMyBP-C interact specifically with myosin,
actin, and tropomyosin (4,5,7–10). cMyBP-C includes a
series of immunoglobulin-like domains and fibronectin
type-3-like domains numbered C0–C10 starting from the
N-terminus (Fig. 1 A) (11), along with a Pro-Ala-rich
sequence and a MyBP-C specific motif (M), which arelikely to be at least partially disordered (12). The C-terminal
domain of cMyBP-C associates with thick filaments (4,8),
while the N-terminal domain interacts with the myosin
motor (9), actin (5,6,10,13,14), and tropomyosin (6,7).
N-terminal domains, including the M-motif, an ~100
amino-acid linker sequence between domains C1 and C2,
have attracted particular attention because the M-motif con-
tains regulatory sites (11,14) and N-terminal fragments
reproduce the action of whole cMyBP-C in many assays.
One such assay is actin motility, where fluorescently-
labeled actin filaments, with or without troponin and tropo-
myosin, are observed moving over a myosin-coated surface.
Actin is propelled by the ATP-dependent force generation
of the myosin heads (Fig. 1 B). Either in the absence of
regulatory proteins or in their presence at high calcium,
actin moves smoothly. Increasing amounts of exogenous
cMyBP-C uniformly decrease actin speed (6,14). Con-
versely, in the presence of regulatory proteins at low
calcium, when actin is normally stationary because tropo-
myosin blocks myosin binding, increasing cMyBP-C has a
biphasic effect, activating actin motility at low concentra-
tions but decreasing actin speed at higher concentrations (6).
The complex activating and inhibitory effects of cMyBP-
C are challenging to explain with a single mechanism.
E.g., while activation might be explained by the ability of
cMyBP-C N-terminal domains to bind to actin and shift
tropomyosin toward the open position (7), inhibition could
result either from competition of cMyBP-C with myosin
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FIGURE 1 Diagrams of cMyBP-C in sarcomeres, motility assays, and in silico. (A) Cartoon of the proteins in muscle contraction,
including cMyBP-C shown extending from the thick filament (myosin) to interact with actin in the thin filament. (Inset) Modular domain
structure of cMyBP-C. (B) Cartoon of a motility assay with a regulated thin filament (actin with troponin and tropomyosin) in the
presence of an N-terminal fragment of cMyBP-C (C0C3). The average spacing of myosin molecules is LM. (Inset) Model assumptions
that cMyBP-C occludes a region of length ‘C on actin and is anchored to the flow cell surface via a linear spring of stiffness kC.
(C and D) Myosin’s and cMyBP-C’s interactions with actin, respectively. (E) The complete model, including actin, myosin, tropomy-
osin, and cMyBP-C N-terminal fragments. Myosin competes with cMyBP-C to bind to actin. Once bound, either cMyBP-C or myosin
displaces tropomyosin toward the open position. If nearby molecules bind, they activate intervening molecules (i.e., molecules 2
and 4 activate molecule 3); if distant molecules bind, they do so independently (i.e., molecules 4 and 7 are independent).
Biophysical Letters 11heads for binding to actin (5) or by transient links between
cMyBP-C and the flow cell surface that create a viscous
drag slowing motility (14). Previously we developed
mathematical models for actin motility without regulatory
proteins (15) or with them at high and low calcium (16).
Here we adapt these models to help distinguish the mecha-
nism(s) by which cMyBP-C affects actin motility (see the
Supporting Material).
This model describes three molecular interactions. The
first, myosin’s ATP-dependent interaction with actin, is
modeled with a four-state scheme (Fig. 1 C). Myosin with
ADP and phosphate (Pi) in its active site binds to actin,
releases Pi and changes conformation, sliding actin forward
a distance d. These steps, not necessarily in that order, result
in a transition from an un-/weakly-bound state to a strongly
bound state with rate constant ka
0. Once strongly bound,
myosin releases ADP with force-dependent rate constant
kDðFÞ ¼ k0DexpðlF=kBTÞ, where kBT is the Boltzmann’s
constant times temperature, and l has the units of distance.
Myosin then detaches from actin with rate constant kT[T],
where [T] is the concentration of ATP. Finally, myosin
hydrolyzes ATP and reverses its conformational change
in a reversible process with forward rate kþh and reverse
rate kh. This model fits many in vitro measurements,
including motility of actin filaments without regulatory
proteins, with parameters, k0a ¼ 40 s1, k0D ¼ 350 s1,
kT ¼ 2 mM1 s1, kþh ¼ 100 s1, kh ¼ 10 s1, d ¼ 10 nm,
l ¼ 1.86 nm, and myosin stiffness kM ¼ 0.3 pN/nm (15).
The second molecular interaction in the model is cMyBP-
C’s with actin. We assume that cMyBP-C is anchored to the
surface of the flow cell, binds specifically to actin, and whenbound, prohibits myosin binding over a region of length ‘C.
Conversely, if a myosin molecule is bound in that region,
cMyBP-C cannot bind to actin. Once bound, cMyBP-C
acts as a linear spring of stiffness, kC. Force-independent
attachment and detachment occur at rates ka
C and kd
C,
respectively (Fig. 1 D). Although these assumptions seem
to presuppose that myosin and cMyBP-C compete for actin
binding sites and that cMyBP-C is attached to the surface,
competition is abolished if ‘C ¼ 0 and attachment is abol-
ished if kC ¼ 0.
The third molecular interaction in the model is cMyBP-C
and myosin with regulatory proteins (Fig. 1 E). Assumed
negligible at high calcium (pCa 5) (16), these interactions
are important at low calcium (pCa 9) where tropomyosin
sterically inhibits the binding of both myosin and cMyBP-
C to actin (7,17). At low calcium, if either myosin or
cMyBP-C binds to actin, tropomyosin is locally displaced
(18), favoring the binding of nearby molecules (7,17).
Assuming that 1) two nearby bound molecules uniformly
displace tropomyosin; 2) two distant bound molecules are
independent; and 3) the transition between these regimes
is abrupt, it follows that two parameters define this local
coupling: C, the maximum number of molecules activated
by a pair of bound molecules; and ε, the actin binding rate
at low calcium relative to the rate at high calcium. This
model describes the motility of regulated thin filaments
(actin with troponin and tropomyosin) at low calcium with
C ¼ 11 and ε ¼ 0.003 (16).
We used this model to fit measurements of actin
motility with skeletal muscle myosin from two groups of
researchers, one group using regulated thin filaments andBiophysical Journal 108(1) 10–13
FIGURE 2 A drag-activation-competition model for MyBP-C is
consistent with measurements of actin motility in the absence
of regulatory proteins (14) or in their presence at high (pCa 5)
and low (pCa 9) calcium (6). (Inset) Models lacking either drag
or activation do not fit the data.
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ments C0C2 and C1C2 (6), and the other using unregulated
actin filaments and variable concentrations of C1C2, C0C2,
C0C3, and C0C1f (the latter includes part of the M-motif)
(14). The two data sets are nearly identical after rescaling
for differences in cMyBP-C concentration (Fig. 2). Rescal-
ing consisted of dividing concentrations of C0C2 and
C1C2 of Razumova et al. (6) by 10 and 14, respectively.
Our qualitative results are independent of rescaling (see
the Supporting Material).
Data were fit by the drag-activation-competition model
(Fig. 2; theory and data not significantly different, p >
0.05, c2 test). We varied the model’s three unknown para-
meters to optimize the fit, PC ¼ kCa/(kCa þ kCd), which
is cMyBP-C’s affinity for actin, b ¼ kCk0D/kMkCd,
which determines the importance of drag, and a ¼ ‘C/LM,
which determines the importance of competition. Best-fit
parameters are PC ¼ 0.83 5 0.09, b ¼ 0.13 5 0.05, and
a ¼ 0.95 0.2.
The model requires both competition and drag to fit the
data. Fits without competition (a ¼ 0) or without drag
(b ¼ 0) are significantly different from the data (p <
0.005, p< 0.001, respectively, c2 test); fits with competition
and drag are significantly better than fits without competi-
tion or without drag (p < 0.005, p < 0.001, respectively,
F-test). Fitting measurements of competition between
myosin and MyBP-C in solution (5) provides independent
estimates of PC ¼ 0.95 0.1 and a ¼ 0.85 0.1, consistent
with the motility fits, further supporting the view that
competition is important in motility (see details in the
Supporting Material).
Optimizing the fit of a mathematical model to data allows
rigorous testing of putative mechanisms. Because it inter-
acts both with contractile and regulatory proteins, devel-
oping a model for cMyBP-C is challenging, inasmuch as
few models for regulation have the computational efficiencyBiophysical Journal 108(1) 10–13necessary for optimization. Here, we developed a model and
showed that a drag-activation-competition mechanism for
cMyBP-C is consistent with actin motility data, whereas
models lacking drag or competition are not (Fig. 2, inset).
These complex effects can arise simply by cMyBP-C bind-
ing to the actin filament: cMyBP-C binding to actin dis-
places tropomyosin at low calcium, leading to filament
activation, whereas increasing cMyBP-C concentration ren-
ders binding sites unavailable to myosin, leading to compe-
tition. Transient links formed by cMyBP-C binding to actin
filaments and to the flow cell surface create a viscous drag
that further slows motility. Future use of this model may
help distinguish mechanistic effects of cMyBP-C mutations
that affect actin binding.SUPPORTING MATERIAL
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